745-752
Original Article
Pretreatment with 5-FU enhances cisplatin cytotoxicity in head and neck squamous cell carcinoma cells
Kei Ijichi, Makoto Adachi, Yasuhisa Hasegawa, Tetsuya Ogawa and Hideaki Nakamura, et al.
753-762
Original Article
The role of topoisomerases and RNA transcription in the action of the antitumour benzonaphthyridine derivative SN 28049
David J. A. Bridewell, Andrew C. G. Porter, Graeme J. Finlay and Bruce C. Baguley
763-768
Original Article
A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer
Hong Suk Song, Young Rok Do, Heung Moon Chang, Min Hee Ryu and Kyung Hee Lee, et al.
769-778
Original Article
An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models
Udai Banerji, Nivedita Sain, Swee Y. Sharp, Melanie Valenti and Yasmin Asad, et al.
779-786
Original Article
Clinical pharmacokinetics of bevacizumab in patients with solid tumors
Jian-Feng Lu, Rene Bruno, Steve Eppler, William Novotny and Bert Lum, et al.
787-797
Original Article
Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model
Joanna Wietrzyk, Dmitry Nevozhay, Magdalena Milczarek, Beata Filip and Andrzej Kutner
799-808
Original Article
7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway
Tzu-Sheng Hsu, Chinpiao Chen, Pei-Ting Lee, Shu-Jun Chiu and Huei-Fang Liu, et al.
809
Erratum
7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway
Tzu-Sheng Hsu, Chinpiao Chen, Pei-Ting Lee, Shu-Jun Chiu and Huei-Fang Liu, et al.
811-819
Original Article
Open AccessCelecoxib inhibits growth of tumors in a syngeneic rat liver metastases model for colorectal cancer
Pieter de Heer, Maro H. Sandel, Gunther Guertens, Gert de Boeck and Margaretha M. Koudijs, et al.
821-830
Original Article
Cytotoxic effects of treosulfan and busulfan against leukemic cells of pediatric patients
Doreen Munkelt, Ulrike Koehl, Stephan Kloess, Stefanie-Yvonne Zimmermann and Rabiá El Kalaäoui, et al.
831-840
Original Article
2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis
Siddhartha Kar, Meifang Wang and Brian I. Carr
841-847
Original Article
Open AccessContinuous ambulatory peritoneal dialysis: pharmacokinetics and clinical outcome of paclitaxel and carboplatin treatment
Joan B. Heijns, Maria E. L. van der Burg, Teun van Gelder, Marien W. J. A. Fieren and Peter de Bruijn, et al.
849-855
Original Article
S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study
Junji Furuse, Takuji Okusaka, Narikazu Boku, Shinichi Ohkawa and Akira Sawaki, et al.
857-865
Original Article
Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells
Chao Ji, Cong Cao, Shan Lu, Rebecca Kivlin and Ashley Amaral, et al.
867-873
Original Article
Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals
Tomohiro Nabekura, Takeshi Yamaki, Kazuyuki Ueno and Shuji Kitagawa
875-880
Original Article
Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer
Geoffrey Y. Ku, David H. Ilson, Lawrence H. Schwartz, Marinela Capanu and Eileen O’Reilly, et al.
881-891
Original Article
In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors
Kenneth M. Rassnick, Josephia R. Muindi, Candace S. Johnson, Cheryl E. Balkman and Nithya Ramnath, et al.
893-902
Original Article
2-Methoxyestradiol reverses doxorubicin resistance in human breast tumor xenograft
Samar S. Azab, Salama A. Salama, Memy H. Hassan, Amani E. Khalifa and Ebtehal El-Demerdash, et al.
903-910
Original Article
Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer
Rupert Bartsch, Catharina Wenzel, Simon P. Gampenrieder, Ursula Pluschnig and Gabriela Altorjai, et al.
911-919
Clinical Trial Report
Cantuzumab mertansine in a three-times a week schedule: a phase I and pharmacokinetic study
Jordi Rodon, Mitchell Garrison, Lisa A. Hammond, Johann de Bono and Lon Smith, et al.
921-923
Short Communication
Androgen receptor expression in prostate cancer stem cells: is there a conundrum?
Nima Sharifi, Elaine M. Hurt and William L. Farrar
925-927
Short Communication
Oxaliplatin-induced immune mediated thrombocytopenia
Muhammad S. Beg, Rami S. Komrokji, Kashif Ahmed and Malek M. Safa
929-930
Letter to the Editor
Successful treatment of non-islet cell tumor hypoglycemia in hepatocellular carcinoma with doxorubicin
Thatchai Kampitak